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Secondary hypertension accounts for about 5% 
of high blood pressure cases. Hyperaldosteron-
ism and pheochromocytoma are not uncommon
causes of secondary hypertension, but the combi-
nation of these two diseases is rare. Here, we report
a hypertensive patient who had unilateral adrenal
hyperplasia with hyperaldosteronism and para-
ganglioma (extra-adrenal pheochromocytoma).
Case Report
A 27-year-old woman was referred to the cardiol-
ogy clinic for evaluation of her hypertension. She
was previously healthy until about 3 months ago
when she suffered from palpitation, dizziness
and headache. High blood pressure of up to
237/131 mmHg was recorded when she visited 
our emergency department for an episode of ab-
dominal discomfort. Thereafter, she reported 
systolic blood pressure 167–170 mmHg and di-
astolic blood pressure 118–132mmHg measured at
home. She had heat intolerance but denied facial
flush. None of her family members has hyper-
tension. Plasma aldosterone level was 711 pg/mL
(78–104 pg/mL in sitting position) and renin
level was 15 pg/mL (16–58 pg/mL in sitting posi-
tion). Spironolactone 25 mg q.d. and bisoprolol
5 mg q.d. were prescribed, and blood pressure
was controlled at about 130/90 mmHg.
When she was hospitalized for further evalua-
tion, she was afebrile, her blood pressure was
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CASE REPORT
148/87 mmHg, pulse rate was 72 beats/min, and
respiratory rate was 18/min. She had no Cushing’s
appearance such as truncal obesity, moon face, 
hirsutism, or fat deposits over the posterior neck.
Physical examination of the heart revealed normal
heart rate and no murmurs, and the lungs were
clear to auscultation bilaterally. The abdomen was
soft and nontender on examination, without bruit.
Radial, femoral and dorsalis pedis pulses were
present and symmetric bilaterally. Extremities were
without edema, cyanosis, clubbing or bruising.
Electrocardiogram and chest radiograph were
unremarkable. Her complete blood count was
normal. Her biochemistry profile showed: Na,
141 mmol/L; K, 4.6 mmol/L; Cl, 103 mmol/L; 
total cholesterol, 254 mg/dL; and triglyceride,
115 mg/dL. The 24-hour urine revealed vanillyl-
mandelic acid (VMA) level of 13.1 mg/day
(1.0–7.5), epinephrine of 4.4 µg/day (0–22.4),
norepinephrine of 430.6 µg/day (11.1–85.5), and
dopamine of 221.2 µg/day (50–450).
Abdominal computed tomography showed a
0.67-cm bulging nodule at the medial limb of the
left adrenal gland, and a 4.2-cm well demarcated,
heterogeneous, left retroperitoneal para-aortic
mass, suggesting an extra-adrenal pheochromo-
cytoma (Figure 1). Magnetic resonance imaging
showed the same para-aortic tumor but no evi-
dence of left adrenal microadenoma. Adrenal
vein sampling for aldosterone and renin sug-
gested hyperaldosteronism of left adrenal origin
(Table).
Left adrenalectomy and excision of the left
retroperitoneal tumor was performed smoothly.
The resected left adrenal gland showed focal corti-
cal hyperplasia with preserved zonal architecture
and no definite tumor was found (Figures 2B–D).
The retroperitoneal mass measured 5.0 × 5.5 ×
3.0 cm in size and 35.0 g in weight, and was firm
and well-demarcated. Microscopically, it showed
sheets or acini bland-appearing tumor cells in del-
icate fibrovascular stroma. The tumor cells had
abundant finely granular basophilic or ampho-
philic cytoplasm with bizarre hyperchromatic
and pleomorphic nuclei. It was confirmed as a
paraganglioma (Figure 2A). After the operation,
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Figure 1. Abdominal computed tomography shows: (A) 0.67-cm bulging nodule at the medial limb of the left adrenal
gland (arrow); (B) 4.2-cm well demarcated left retroperitoneal para-aortic mass (arrow) at the level of the lower pole of
the right kidney.
Table. Results of adrenal vein sampling
IVC (above adrenal IVC (below adrenal Left adrenal 
Right adrenal vein
vein) vein) vein
Renin (pg/mL) 15.26 14.81 13 15.28
Aldosterone (pg/mL) 868.26 686.45 5480.54 482.23
Hypertension due to paraganglioma and adrenal cortical hyperplasia
her blood pressure returned to normal without
the use of antihypertensive medication, and her
plasma aldosterone, renin and urine VMA levels all
returned to within normal ranges (71.96 pg/mL,
48.32 pg/mL, and 3.30 mg/day, respectively).
Discussion
The simultaneous occurrence of extra-adrenal
pheochromocytoma and unilateral adrenal corti-
cal hyperplasia is extremely rare. Only two cases
have previously been reported in the English 
literature.1,2 The relationship between these two
conditions is not known. Based on the coexis-
tence of adrenal pheochromocytoma and corti-
cal adenoma, some authors have postulated that
the interaction of contiguous adrenal medullary
and cortical tissues may exist, and catecholamine
(or other substance) secreted by pheochromo-
cytoma will stimulate cortical hyperplasia and
subsequently adenoma formation.3,4 However,
whether this interaction exists between extra-
adrenal pheochromocytoma and adrenal cortex
remains unclear. Madison showed that it was epi-
nephrine, not norepinephrine, that stimulated
ACTH release and induced hyperplasia of the ad-
renal cortex in an experimental animal model.5
Since most extra-adrenal pheochromocytomas
secrete norepinephrine,6 as in this case, the coex-
istence of extra-adrenal pheochromocytoma and
adrenal cortical hyperplasia may be coincidental.
Occasionally, pheochromocytoma is accompa-
nied by elevated plasma renin activity, leading to
secondary hyperaldosteronism (epinephrine has
greater renin-stimulating activity than norepi-
nephrine).7,8 Hsieh et al thought that chronic
secondary hyperaldosteronism may lead to the
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Figure 2. (A) Histologic section of the extra-adrenal paraganglioma shows cells with abundant finely granular basophilic
or amphophilic cytoplasm; bizarre hyperchromatic and pleomorphic nuclei are also noted (hematoxylin & eosin, 400×).
The resected left adrenal gland: (B) zona glomerulosa; (C) zona fasciculate; (D) zona reticularis. There is only focal corti-
cal hyperplasia, and no tumor is seen (hematoxylin & eosin, 400×).
development of autonomous aldosterone excess
and adenoma formation; as aldosterone secre-
tion increased and body fluid expanded, renin
secretion would be suppressed.3 However, in this
case, if the adrenal abnormality is caused by
extra-adrenal paraganglioma secreting substance,
it should be bilateral, not unilateral. Gordon et al
also suggested that the simultaneous presence of
pheochromocytoma and primary aldosteronism
is probably a chance occurrence.2
The symptoms of palpitation and headache in
this patient could be induced by paraganglioma
(extra-adrenal pheochromocytoma). Pheochromo-
cytoma is a catecholamine-secreting tumor that
arises from chromaffin cells. Because most chro-
maffin cells degenerate after birth, with the ex-
ception of those in the adrenal medulla, most
pheochromocytomas (85–95%) are found in the
adrenal gland. Extra-adrenal pheochromocytoma
occur most commonly in the organ of Zuckerkandl
(75%) as in this case, but may also be found in
the thorax, abdomen, pelvis, mediastinum and
neck.9 Pheochromocytomas that secret epineph-
rine are particularly likely to be found in the adre-
nal medulla. Extra-adrenal paragangliomas rarely
secret epinephrine. This is due to their lack of im-
mediate proximity to the adrenal cortex, which
ordinarily provides the high concentrations of
cortisol needed for induction of the enzyme
phenylethanolamine-N-methyl-transferase
(PNMT), which catalyzes the conversion of 
norepinephrine to epinephrine.6 If the predomi-
nant secretion of the tumor is epinephrine, the 
symptoms will reflect its effect, mainly systolic
hypertension caused by increased cardiac output,
tachycardia, sweating, flushing, and apprehen-
sion. If norepinephrine is predominately secreted,
as from some adrenal tumors and from almost all
extra-adrenal tumors, the symptoms will include
both systolic and diastolic hypertension from pe-
ripheral vasoconstriction but less tachycardia, pal-
pitation and anxiety.10 There was no tachycardia,
sweating or facial flushing in this case, but there
was systolic and diastolic hypertension. These
findings suggest that the main hormone secreted
in this patient was norepinephrine, which was
compatible with urine catecholamine analysis.
The serum potassium level of this patient was
not checked initially, and it was 4.6 mmol/L after
taking spironolactone. She had no symptoms in-
duced by hypokalemia such as muscle weakness.
However, classical features of hypokalemia and
metabolic alkalosis can be absent even in the pres-
ence of marked hypertension. Recent evidence
suggests that the prevalence of primary hyperal-
dosteronism is higher than originally thought.11
In an Australian tertiary practice, Hamlet et al found
that the majority of patients (70%) with primary
aldosteronism were normokalemic.12
Primary aldosteronism is usually caused by
an aldosterone-producing adenoma or bilateral
adrenal hyperplasia that comprise about 65%
and 30% of cases, respectively. However, 5% of
primary aldosteronism are caused by other etiol-
ogy such as unilateral adrenal hyperplasia—a rel-
atively rare subset of adrenal hyperplasia with an
approximate prevalence of less than 1% of all
cases of primary aldosteronism.13 Unilateral ad-
renal hyperplasia usually mimics unilateral adre-
nal adenoma and is difficult to diagnose before
resection.14 Computed tomography is unreliable
in diagnosing patients with unilateral adrenal
hyperplasia. Goh et al found that computed to-
mographic examination correctly localized uni-
lateral adrenal hyperplasia in 53% (9/17) of
patients; in contrast, adrenal vein sampling is the
most accurate test, which localized the lesion
side successfully in all patients (22/22) in whom
it was performed.15 Unilateral adrenal hyper-
plasia can present with normokalemia, and it is
probably an early phase of the transformation be-
tween hyperplasia and adenoma.16 Shigematsu
et al, who studied mRNA expression for steroido-
genic enzymes in adrenal cortices, also postulated
that adrenal micronodules might ultimately be-
come adenoma by repeated growth and fusion.17
We reported a case of secondary hypertension
caused by extra-adrenal paraganglioma and left
adrenal cortical hyperplasia. The combination of
these two conditions is unusual and the interaction
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between them remains uncertain. Further inves-
tigation is needed.
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